These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36440049)

  • 1. Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review.
    Lokhorst C; van der Werf S; Berger RMF; Douwes JM
    Front Cardiovasc Med; 2022; 9():1035453. PubMed ID: 36440049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.
    Lokhorst C; van der Werf S; Berger RMF; Douwes JM
    J Am Heart Assoc; 2024 Jul; 13(13):e034151. PubMed ID: 38904230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction Models and Scores in Pulmonary Hypertension: A Review.
    Mouratoglou SA; Bayoumy AA; Noordegraaf AV
    Curr Pharm Des; 2021; 27(10):1266-1276. PubMed ID: 33155897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension.
    Haddad F; Contrepois K; Amsallem M; Denault AY; Bernardo RJ; Jha A; Taylor S; Arthur Ataam J; Mercier O; Kuznetsova T; Vonk Noordegraaf A; Zamanian RT; Sweatt AJ
    Chest; 2022 May; 161(5):1347-1359. PubMed ID: 34774527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.
    Xanthouli P; Koegler M; Marra AM; Benjamin N; Fischer L; Eichstaedt CA; Harutyunova S; Nagel C; Grünig E; Egenlauf B
    Respir Res; 2020 May; 21(1):127. PubMed ID: 32448256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalency of Multiple Biomarkers to Clinical Pulmonary Arterial Hypertension Survival Risk Models.
    Griffiths M; Simpson CE; Yang J; Vaidya D; Nies MK; Brandal S; Damico R; Hassoun P; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Martin LJ; Rosenzweig EB; Benza RL; Nichols WC; Manlhiot C; Everett AD
    Chest; 2024 Dec; 166(6):1511-1531. PubMed ID: 39154795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-center prognostic validation of the risk assessment of the 2015 ESC/ERS guidelines in patients with pulmonary arterial hypertension in Japan.
    Imai R; Adachi S; Yoshida M; Shimokata S; Nakano Y; Okumura N; Murohara T; Kondo T
    Can J Physiol Pharmacol; 2020 Sep; 98(9):653-658. PubMed ID: 32924564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Hendriks PM; van de Groep LD; Veen KM; van Thor MCJ; Meertens S; Boersma E; Boomars KA; Post MC; van den Bosch AE
    Am Heart J; 2022 Aug; 250():34-44. PubMed ID: 35533723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Li J; Xiong J; Liu P; Peng Y; Cai S; Fang X; Yu S; Zhao J; Wu R
    Adv Rheumatol; 2024 Feb; 64(1):15. PubMed ID: 38424650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools.
    Dardi F; Guarino D; Ballerini A; Bertozzi R; Donato F; Cennerazzo F; Salvi M; Nardi E; Magnani I; Manes A; Galiè N; Palazzini M
    ERJ Open Res; 2024 Jul; 10(4):. PubMed ID: 39104950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension.
    Bouzina H; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2021 Feb; 55(1):35-42. PubMed ID: 32597241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.
    Suen CM; Zhai A; Lalu MM; Welsh C; Levac BM; Fergusson D; McIntyre L; Stewart DJ
    Syst Rev; 2016 May; 5():89. PubMed ID: 27225668
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.